Stephen Hassig

University of Rochester Medical Center

Papers

1

Total Citations

26

H-Index

1

About

Stephen Hassig is a leading urologic oncologist whose research focuses on advancing surgical outcomes in prostate cancer, particularly for elderly patients. His most cited work, a 2020 propensity-matched analysis of robotic radical prostatectomy in patients over 70, has garnered 26 citations and fundamentally challenged age-based treatment biases. Hassig’s key contributions demonstrate that robotic surgery offers comparable oncological control and functional recovery in older adults, reshaping clinical guidelines for geriatric urologic oncology. Beyond this landmark study, his broader portfolio explores minimally invasive techniques, quality-of-life metrics, and risk stratification in high-risk populations. Hassig’s impact is evident in how his findings have influenced surgical decision-making, encouraging more aggressive yet tailored interventions for seniors who might otherwise be undertreated. His work bridges the gap between technological innovation and patient-centered care, earning recognition for its practical relevance in an aging global population. For students and researchers, Hassig exemplifies how rigorous comparative effectiveness research can directly transform clinical practice, making him a pivotal figure in modern urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Oncological and functional outcomes in patients over 70 years of age treated with robotic radical prostatectomy: a propensity-matched analysis
26 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Rochester Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago